North America Single Use Assemblies Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)
North America Single Use Assemblies Market: by Type (Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Mixing System Assemblies, Tube Assemblies, Other Types), Application (Filtration, Cell Culture & Harvesting, Processing, Storage, Sampling, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Specialty Stores, Retail Stores, Others), Technology (Standard Technology, Customized Assemblies, Aseptic Technology, Modular Assemblies, Gamma Sterilized Assemblies, Single-Use Sensors), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Last Updated: 31-07-2025 | Format: PDF | Report ID:20342 | Author: Ankita R
North America Single Use Assemblies Market, 2025-2035
The North America Single Use Assemblies Market encompasses ready-to-use, presterilized systems deployed extensively in biopharmaceutical and pharmaceutical production for robust aseptic processing. These assemblies include custom-configured combinations of tubing, bags, filters, and connectors designed for single use, significantly mitigating contamination risks and turnaround times. The market has witnessed dynamic expansion driven by advancements in bioprocessing, heightened adoption of disposable systems, and stringent regulatory frameworks prioritizing safety and sterile processing. Rapid innovations—such as integrated sensors and modular assembly architectures—are transforming operational flexibility and process monitoring, supporting the growing trend towards personalized medicines and flexible manufacturing platforms. With continuous investments in biotechnology, demand for scalable, cost-effective, and sustainable production solutions is accelerating, forging lucrative growth pathways across the United States, Canada, and Mexico.
Latest Market Dynamics
Key Drivers
Rapid expansion of biopharmaceutical manufacturing, notably driven by advancements in monoclonal antibodies and vaccines. Thermo Fisher Scientific announced new capacity expansions and bioprocessing solutions in 2024 to cater to this surging demand.
Increased preference for contamination-free operations and reduced cross-contamination risk. Sartorius AG launched advanced aseptic, pre-validated bag assemblies in 2024 for enhanced sterility assurance.
Key Trends
Adoption of integrated single-use sensors for real-time monitoring, with Merck KGaA debuting next-generation single-use assemblies embedded with PAT-compatible sensors in 2024.
Custom-configured and modular assemblies gaining traction to address complex bioprocessing needs; Danaher Corporation unveiled modular single-use systems for high-mix, low-volume production environments in early 2024.
Key Opportunities
Rising investments in personalized medicine and cell therapy manufacturing, boosting demand for flexible, scalable single-use solutions. In 2024, Lonza Group AG enhanced its offerings for advanced therapy production.
Growing biosimilars market leading to increased utilization of cost-effective single-use assemblies. Avantor Inc. partnered with leading biosimilar manufacturers in June 2024 to deliver tailored assemblies.
Key Challenges
Complex validation requirements and regulatory compliance for customized assemblies; Merck KGaA reported increased compliance investments in 2024 to align with evolving US FDA norms.
Supply chain disruptions impacting availability of high-purity polymers and specialty components, directly affecting players like Entegris, Inc. who announced mitigation strategies in July 2024.
Key Restraints
High initial adoption costs for transitioning from traditional stainless-steel setups; new market entrants such as Flexbiosys, Inc. highlighted these hurdles at the 2024 ISPE Biotech Workshop.
Waste management and environmental concerns regarding disposal of single-use plastics, with Saint-Gobain intensifying its sustainable product development initiatives since mid-2024.
Bag assemblies are dominating the single-use assemblies market in North America with the largest percentage share, benefiting from their versatility across upstream and downstream bioprocessing. Filtration assemblies have cemented their position owing to increasing requirements for sterility and particulate removal, while bottle and mixing system assemblies also command significant adoption rates. With the expansion of modular and easily reconfigurable assemblies, tube assemblies and niche product segments are showing rapid growth. These evolving preferences reflect both the ongoing bioprocessing modernization and pharmaceutical manufacturers’ requirements for operational agility and sterility.
Filtration stands as the foremost application in North America's single-use assemblies market, supported by stringent regulatory compliance and the need for high product purity in biomanufacturing workflows. Cell culture and harvesting follows closely, propelled by the accelerated implementation of single-use technologies in upstream processing. Applications in processing, storage, and sampling are collectively gaining ground through innovation in modular designs and real-time analytics integration, while niche and emerging uses remain a small but rapidly evolving market segment. These patterns reflect the sector’s pivot to continuous processing, process intensification, and precision control in biologics production.
The North America single use assemblies market revenue is projected to show consistent double-digit growth through 2035. Starting at $1,080 Million in 2020, the market saw accelerated expansion in the wake of the COVID-19 pandemic, driven by demand for flexible, rapid deployment solutions. By 2025, revenues are expected to reach $2,450 Million, with forecasts suggesting a climb up to $6,870 Million by 2035. This upward trajectory is attributed to increasing adoption of single use systems across major biomanufacturing hubs, expansion of biologics, and heightened R&D activity in personalized medicines.
The North American single use assemblies market has experienced a robust year-on-year (YOY) growth rate, predominantly above 10% since 2020. Between 2020 and 2025, a remarkable YOY surge from 14.8% to 21.4% was induced by heightened demand for rapid, aseptic manufacturing during the pandemic. Steady industrialization and biopharma advancements sustain growth above 8% through 2030, gradually moderating to 3% by 2035 as the market matures. This gradual normalization emphasizes the stabilization post-exponential adoption phase and signals retained innovation and expansion capacity within leading North American geographies.
The United States dominates the North American single use assemblies market, accounting for almost four-fifths of total market revenue in 2025. Canada captures a solid share as its biomanufacturing infrastructure rapidly modernizes, particularly within Ontario and Quebec. Mexico’s burgeoning pharmaceutical sector continues to develop, supported by incentives for bioprocessing innovation. The market’s regional distribution reflects robust investment, established talent pools, and intense R&D activity anchored in the US, complemented by accelerating growth in Canada and Mexico.
Sartorius AG, Thermo Fisher Scientific, and Merck KGaA together command just over half of the North America single use assemblies market, reflecting their deep portfolios, worldwide logistics, and continuous innovation. Danaher Corporation and Parker Hannifin are key challengers with advanced assembly platforms and customer-centric models. Multiple mid-tier and emerging vendors like RoosterBio Inc. and Flexbiosys, Inc. are capturing niche segments, indicating continued market dynamism and scope for specialized solutions. Strategic alliances, product expansions, and technology licensing remain pivotal competitive factors.
Biopharmaceutical manufacturers dominate the buyer landscape for single use assemblies, representing over half of total demand due to broad adoption in upstream and downstream processes. CDMOs and CROs exhibit marked growth as outsourcing trends intensify, while academic and research institutions steadily embrace single-use for pilot studies and experimental scale-up. Hospital and clinical laboratories, though smaller in share, are expanding their usage with the convergence of precision medicine and point-of-care technologies. These dynamics spotlight the growing diversity of end-users and underline innovation-led procurement strategies.
Study Coverage
Metrics
Details
Years
2020-2035
Base Year
2025
Market Size
2450
Regions
North America, United States, Canada, Mexico
Segments
Type: Bag Assemblies, Filtration Assemblies, Bottle Assemblies, Mixing System Assemblies, Tube Assemblies, Other Types; Application: Filtration, Cell Culture & Harvesting, Processing, Storage, Sampling, Others; Distribution Channels: Direct Sales, Distributors, Online Sales, Specialty Stores, Retail Stores, Others; Technology: Standard Technology, Customized Assemblies, Aseptic Technology, Modular Assemblies, Gamma Sterilized Assemblies, Single-Use Sensors; Organization Size: Small, Medium, Large
June 2024: Thermo Fisher Scientific announced a new state-of-the-art single-use manufacturing center in Massachusetts to support bioprocessing growth.
July 2024: Entegris, Inc. launched a high-purity, rapid-delivery program for critical single-use assembly components in partnership with leading biotech firms.
August 2024: Merck KGaA’s Life Science business introduced the BioReliance® Single-Use Sensor Assembly platform with embedded PAT for advanced real-time monitoring.
September 2024: Avantor Inc. expanded its biosimilars-focused single-use assembly portfolio via a strategic collaboration with a global CDMO.
October 2024: Danaher Corporation unveiled its FlexSuite Modular Assembly Systems designed for flexible and rapid multi-product biomanufacturing.
Frequently Asked Questions
About the Author
Ankita R
Lead Industry Analyst
Ankita R is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Ankita R brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Ankita R has helped organizations translate data into actionable growth strategies.
